Overview

Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants

Status:
Completed
Trial end date:
2019-11-19
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the PK of digoxin administered alone and in combination with AMG 510 in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen
Treatments:
Digoxin